Peripherally Inserted Central Catheters Market, by Product Type (Single Lumen, Double Lumen, and Multi Lumen), by End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Catheterization Laboratories), and by Region (North America, Latin America, E

Peripherally Inserted Central Catheters Market, by Product Type (Single Lumen, Double Lumen, and Multi Lumen), by End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Catheterization Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

A peripherally inserted central catheter (PICC), also called a PICC line, is a long, thin tube that's inserted through a vein in arm and passed through to the larger veins near the heart. A peripherally inserted central catheter (PICC) is used as a medium to insert medications or liquid nutrition. A PICC line can help to avoid the pain of frequent needle sticks and reduce the risk of irritation to the smaller veins in arms. A PICC line is usually intended to be temporary and might be an option if your treatment is expected to last up to several weeks. A PICC line requires careful care and monitoring for complications, including infection and blood clots. A peripherally inserted central catheter (PICC) line is recommended for cancer treatment, liquid nutrition, infection treatment, and other medications.
Market Dynamics
Peripherally inserted central catheters are widely used in chemotherapy treatments. Hence, prevalence of cancer is propelling the demand for cancer treatment and care, which, in turn, is expected to drive the market growthFor instance, According to the World Health Organization (WHO) report, in February 2018, cancer was the second-leading cause of death globally, and around 18.1 million new cases and 9.6 million deaths were registered due to cancer. According to the same source, around 70% of deaths from cancer occurred in low- and middle-income countries and around 1 in 6 deaths across the globe are caused by cancer.in February 2015, Teleflex Incorporated, a provider of medical devices, launched triple-lumen version of unique Arrow PICC with Chlorag+ard Technology (antimicrobial and antithrombogenic) (offered by Teleflex Incorporated) to significantly reduce the risk of central line-associated bloodstream infections (CLABSI) and PICC-related vessel thrombosis.
However, the use of conventional peripherally inserted central catheters involves high risk of blood stream infection due to lack of extreme hygiene condition required at the peripherally inserted central catheters insertion point, which reduces its feasibility over a longer period of time. Such scenario is expected to hinder growth of the global peripherally inserted central catheters market. For instance, a study named ‘Complications with peripherally inserted central catheters (PICCs) used in hospitalized patients and outpatients: a prospective cohort study’ was published in the BMC Journal in January 2017, which stated that occlusion, infections, and accidental withdrawal are the most common complications associated with peripherally inserted central catheters. Moreover, according to the same source, the overall complication rate for peripherally inserted central catheters was estimated to be around 30.2% (11.1 per 1,000 PICC-days).
Key features of the study:
This report provides in-depth analysis of the global peripherally inserted central catheters market size (US$ 1,369.9 Mn), and compound annual growth rate (CAGR) 6.9% for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global anti-epileptic drug market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include AngioDynamics Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Teleflex Incorporated, Argon Medical Devices, Inc., Cook Medical Inc., ICU Medical, Inc., Medical Components, Inc., Access Vascular, and Vygon (UK) Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global peripherally inserted central catheters market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for drug market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Global Peripherally Inserted Central Catheters Market, By Product Type:
Single Lumen
Double Lumen
Multi Lumen
Global Peripherally Inserted Central Catheters Market, By End user:
Hospitals & Clinics
Ambulatory Surgical Centers
Catheterization Laboratories
Global Peripherally Inserted Central Catheters Market, By Region:
North America
By Country:
U.S.
Canada
By Product Type:
Single Lumen
Double Lumen
Multi Lumen
By End User:
Hospitals & Clinics
Ambulatory Surgical Centers
Catheterization Laboratories
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Product Type:
Single Lumen
Double Lumen
Multi Lumen
By End User:
Hospitals & Clinics
Ambulatory Surgical Centers
Catheterization Laboratories
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Product Type:
Single Lumen
Double Lumen
Multi Lumen
By End User:
Hospitals & Clinics
Ambulatory Surgical Centers
Catheterization Laboratories
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Product Type:
Single Lumen
Double Lumen
Multi Lumen
By End User:
Hospitals & Clinics
Ambulatory Surgical Centers
Catheterization Laboratories
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Product Type:
Single Lumen
Double Lumen
Multi Lumen
By End User:
Hospitals & Clinics
Ambulatory Surgical Centers
Catheterization Laboratories
Africa
By Country/Region:
South Africa
Central Africa
North Africa
By Product Type:
Single Lumen
Double Lumen
Multi Lumen
By End User:
Hospitals & Clinics
Ambulatory Surgical Centers
Catheterization Laboratories
Company Profiles
AngioDynamics Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
B. Braun Melsungen AG
Becton, Dickinson and Company.
Teleflex Incorporated.
Argon Medical Devices, Inc.
Cook Medical Inc.
ICU Medical, Inc.
Medical Components, Inc.
Access Vascular
Vygon (UK) Ltd.
“*” marked represents similar segmentation in other categories in the respective section.